Literature DB >> 8664197

High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma.

E Zucca1, G Pinotti, E Roggero, M A Comi, A Pascarella, C Capella, E Pedrinis, F Cavalli.   

Abstract

BACKGROUND: Low-grade gastric MALT lymphoma is an uncommon tumour for which a close association with chronic Helicobacter pylori infection has been suggested. However, given the rarity of MALT lymphoma of the stomach despite the high prevalence of H. pylori infection, it seems plausible that genetic host factors might play a fundamental role in gastric lymphomagenesis. PATIENTS AND METHODS: We retrospectively reviewed the medical records of 83 patients with low-grade gastric MALT, all of whom resided in a geographic area (southern Switzerland and northern Italy) where the incidence of gastric tumours appears to be uncommonly high.
RESULTS: One or more additional cancers were observed in 17 of 83 patients (20%, 95% CI 12% to 31%) for a total of 23 tumours. Of these, 5 were diagnosed prior to, 12 concomitantly with, and 7 after the gastric MALT lymphoma. Eleven patients had a single additional solid tumour (13%, 95% CI 7% to 22%); 3 patients had non-Hodgkin's lymphoma and one had Hodgkin's disease. Multiple additional cancers were present in 3 cases. Nine of 83 patients have died and 8 of them of a second cancer.
CONCLUSIONS: Unexpectedly an extraordinarily large number of patients with other malignancies was observed in this series. The reasons for this finding are still unknown, but genetic alterations are speculated to play an important role.

Entities:  

Mesh:

Year:  1995        PMID: 8664197     DOI: 10.1093/oxfordjournals.annonc.a059292

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  7 in total

1.  Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type.

Authors:  A Morgner; S Miehlke; M Stolte; A Neubauer; B Alpen; C Thiede; H Klann; F X Hierlmeier; C Ell; G Ehninger; E Bayerdörffer
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Colonic MALToma: a case report and review of the literature.

Authors:  Lawrence Toquero; Omar M Aboumarzouk; Sandro Lanzon-Miller
Journal:  BMJ Case Rep       Date:  2009-05-08

3.  Risk of second malignancies in patients with gastric marginal zone lymphomas of mucosa associate lymphoid tissue (MALT).

Authors:  Masahiro Tajika; Keitaro Matsuo; Hidemi Ito; Dai Chihara; Vikram Bhatia; Shinya Kondo; Tsutomu Tanaka; Nobumasa Mizuno; Kazuo Hara; Susumu Hijioka; Hiroshi Imaoka; Kazuya Matsumoto; Tsuneya Nakamura; Yasushi Yatabe; Kenji Yamao; Yasumasa Niwa
Journal:  J Gastroenterol       Date:  2013-06-25       Impact factor: 7.527

Review 4.  Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives.

Authors:  Dominic Kaddu-Mulindwa; Lorenz Thurner; Konstantinos Christofyllakis; Moritz Bewarder; Igor Age Kos
Journal:  Cancers (Basel)       Date:  2022-06-19       Impact factor: 6.575

Review 5.  The diminishing role of surgery in the treatment of gastric lymphoma.

Authors:  Sam S Yoon; Daniel G Coit; Carol S Portlock; Martin S Karpeh
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

Review 6.  Mucosa-associated lymphoid tissue lymphomas.

Authors:  M Gospodarowicz; R Tsang
Journal:  Curr Oncol Rep       Date:  2000-03       Impact factor: 5.945

7.  The role of radiotherapy in the treatment of gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Taek-Keun Nam; Jae-Sook Ahn; Yoo-Duk Choi; Jae-Uk Jeong; Yong-Hyeob Kim; Mee Sun Yoon; Ju-Young Song; Sung-Ja Ahn; Woong-Ki Chung
Journal:  Cancer Res Treat       Date:  2014-01-15       Impact factor: 4.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.